Contract Service Providers Gear Up to Develop Emerging Therapies
Technology advances enable contract service providers to keep pace with the demands of existing and emerging biologic-based therapies.
Biopharma Service Providers Address a Full Plate of Challenges
Contract service providers debate the pros and cons of consolidation, accelerated drug approvals, regulatory issues, and the impact of new therapies.
Dealing with Pharmaceutical Supply-Chain Complexities
Planning ahead is key to enabling a continuous and secure supply chain that adapts to changes in market demand.
Keeping it Simple: Collaborating for Success in Drug Delivery
For successful drug delivery partnerships, it’s important to take a long-term view, focus on simple designs, and address potential payer concerns up front.
Regulatory Reform in China: Implications for Global Biopharmaceutical Companies
New drug approval policies promote industry growth and injectable contract manufacturing opportunities in China.
Biomanufacturers Demand Higher Quality Standards in 2016
Biopharmaceutical manufacturers continue to put quality at the forefront of their relationships.
Preventing Phase III Failures
Adopting best practices and collaborating more closely with contract research organizations can help drugs get past Phase III.
Outsourcing Industry Marked by Considerable Investments in 2016
Biopharmaceutical contractors continue to invest in development, facility upgrades, technological advancement, and mergers and acquisitions.
